Closing Bell: Nervgen Pharma Corp down on Tuesday (NGEN)

In today's trading, Nervgen Pharma Corp shares closed at $2.28 after opening the day at $2.33. prices ranged from $2.27 to $2.34.

Share prices shrank -0.87 percent from the previous day's close of $2.30.

Today across North America, the TSX Composite closed 0.11% at 21611.30, the S&P 500 closed 0.77% at 5473.23, the Dow Jones Industrial Average closed 0.49% at 38778.10 and the Nasdaq Composite closed 0.95% at 17857.02.

Nervgen Pharma Corp has listed on the Toronto Venture Exchange (TSX-V) under the ticker NGEN.

Trading volume was 77,977 on 137 total trades. On average, Nervgen Pharma Corp has traded 107,102 shares over the last 5-days and 90,921 year-to-date.

The TSX-V overall saw 2,250 price advancers against 2,973 declines and 102 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, in the last 12 months, Nervgen Pharma Corp's shares have advanced 36.53 percent, while they have decreased -15.56% since the start of 2024.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $160.83 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Nervgen Pharma Corp's average recommendation is "Strong Sell" based on 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..